BioSpace News Archive

SPARK Offers the Latest Advancements in Clear Aligners and an Experience That is Recommended by 100% of Patients*

Aidoc , the leading provider of enterprise AI solutions, and Imbio , a leading provider of medical image analysis for pulmonary and cardiothoracic diseases, announced today a partnership intended to provide the world’s first end-to-end AI solution for pulmonary embolism (PE), with the goal of ultimately improving efficiency and quality

As education systems grapple with teaching during the pandemic, CIC Health uses the ixlayer COVID-19 Clinical Testing Platform to enable routine testing

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced three amyotrophic lateral sclerosis (ALS) presentations as part of the Motor Neurone Disease Association (MNDA) 31 st International Symposium on ALS/MND, which is being held virtually December 9-11 .

Vault, a performance healthcare technology platform and leader in saliva at-home COVID-19 testing, has announced their latest C-Suite hire, Steve Shi, as Chief Technology Officer.

Octapharma USA will present multiple clinical research posters focused on the efficacy and safety of fibryga ® , Fibrinogen (Human) Lyophilized Powder for Reconstitution, for Intravenous Use in the treatment of congenital and acquired bleeding disorders during the 62 nd American Society of Hematology (ASH) Annual Meetin

Today, the Multiple Myeloma Research Foundation (MMRF) and Dana-Farber Cancer Institute jointly announced a pioneering research collaboration in smoldering myeloma (SMM), a precursor disease to multiple myeloma. Combining the strengths of the MMRF, a leader in multiple myeloma data generation, and Dana-Farber, a leader in SMM research, the initiative aims to revolutionize how SMM patients are treated. The ulti

Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders, today announced the appointment of David Wheadon, M.D.,

Leading Clinical Experts Discuss Advancing Personalized Breast Cancer Screening and Detection with Newly Launched ProFound AI Risk Added Market Growth Opportunit y Presented by Pioneering AI Breast Cancer Risk Offering Webinar Taking Place on Monday, December 7 @ 11am ET

With families continuing to work and attend school in the midst of rising COVID outbreaks, screening for fever, a primary symptom of COVID-19, has never been more important.